ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
FASgen Announces New Research Discoveries In Lung Cancer
FASgen is pleased to report the
publication of important research results for lung cancer treatment using
FAS093, one of the Company's proprietary compounds. In a long-standing
cooperation with The Johns Hopkins Oncology Center, FASgen supported
research into the selective inhibition of fatty acid synthase (FASi) at the
Hopkins Oncology Center as a potential therapeutic agent against various
forms of solid tumor cancers. In the recently reported study results,
researchers at the Hopkins Oncology Center found that FAS093 significantly
inhibited growth of several different xenograft tumors from human NSCLC
cell lines. These extremely interesting results appear in the article,
"Selective Inhibition of Fatty Acid Synthase for Lung Cancer Treatment,"
Gabrielson et al, Clin Cancer Res 200l, 13(23) 7139-7145 (Dec. 1, 2007).
About FASgen, Inc.: FASgen, Inc. is a drug development company founded
in 2000 by four distinguished Johns Hopkins researchers to create new
therapeutic products based on the selective inhibition of fatty acid
biosynthesis. The Company has the exclusive license from Johns Hopkins to
more than 15 years of research in the field, which research continues under
a sponsored research agreement with the University.
The Company has designed and synthesized many compounds that
selectively inhibit fatty acid biosynthesis. One group of these compounds
holds great promise for new highly specific therapeutics for cancer;
additional compounds have the potential of specific therapeutics for
obesity and related metabolic disorders; and, an additional group of
compounds have the potential of specific therapeutics for TB, including
multiple drug resistant TB (MDR-TB) and latent TB infections that affect
one third of the world's population. For more information, visit FASgen's
website at http://www.fasgen.com
FASgen, Inc.
http://www.fasgen.com
FASgen Announces Nou Cercetare Descoperiri În Cancerul pulmonar - FASgen Announces New Research Discoveries In Lung Cancer - articole medicale engleza - startsanatate